US EditionAustralia Only Approved 1 of the 2 New Alzheimer's 'Mab' Drugs: Kisunla
Summary by Being Patient
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Australia Only Approved 1 of the 2 New Alzheimer's 'Mab' Drugs: Kisunla
After being rejected by EU regulators but approved in the U.S., UK, and several Middle Eastern countries, Alzheimer’s drug Kisunla added a new market:... The post Australia Only Approved 1 of the 2 New Alzheimer’s ‘Mab’ Drugs: Kisunla appeared first on Being Patient.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
